TY  - GEN
AU  - Goy,A
AU  - Bernstein,S H
AU  - Kahl,B S
AU  - Djulbegovic,B
AU  - Robertson,M J
AU  - de Vos,S
AU  - Epner,E
AU  - Krishnan,A
AU  - Leonard,J P
AU  - Lonial,S
AU  - Nasta,S
AU  - O'Connor,O A
AU  - Shi,H
AU  - Boral,A L
AU  - Fisher,R I
TI  - Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study
SN  - 1569-8041
PY  - 2009///0519
KW  - Aged
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Boronic Acids
KW  - Bortezomib
KW  - Female
KW  - Humans
KW  - Lymphoma, Mantle-Cell
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Pyrazines
KW  - Survival Rate
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdn656
ER  -